JPMorgan Chase & Co. started coverage on shares of GlaxoSmithKline (LON:GSK) in a research report released on Tuesday, Borsen Zeitung reports. The firm issued a neutral rating and a GBX 1,700 ($22.21) price objective on the stock.
GSK has been the subject of a number of other research reports. Kepler Capital Markets raised their price objective on shares of GlaxoSmithKline from GBX 1,440 ($18.82) to GBX 1,540 ($20.12) and gave the stock a hold rating in a report on Tuesday, June 11th. Jefferies Financial Group restated a buy rating on shares of GlaxoSmithKline in a report on Friday, May 24th. Liberum Capital restated a hold rating on shares of GlaxoSmithKline in a report on Tuesday, July 2nd. HSBC set a GBX 1,942 ($25.38) price objective on shares of GlaxoSmithKline and gave the stock a buy rating in a report on Tuesday, July 16th. Finally, Deutsche Bank restated a hold rating and set a GBX 1,620 ($21.17) price objective (up previously from GBX 1,575 ($20.58)) on shares of GlaxoSmithKline in a report on Friday, July 26th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average target price of GBX 1,638.06 ($21.40).
LON GSK opened at GBX 1,645.60 ($21.50) on Tuesday. GlaxoSmithKline has a 52-week low of GBX 1,408.80 ($18.41) and a 52-week high of GBX 1,749.40 ($22.86). The company has a 50-day simple moving average of GBX 1,652.42 and a 200 day simple moving average of GBX 1,575.27. The company has a debt-to-equity ratio of 1,127.74, a quick ratio of 0.44 and a current ratio of 0.71. The company has a market capitalization of $82.08 billion and a PE ratio of 18.53.
The firm also recently announced a dividend, which will be paid on Thursday, October 10th. Stockholders of record on Thursday, August 8th will be paid a GBX 19 ($0.25) dividend. The ex-dividend date is Thursday, August 8th. This represents a dividend yield of 1.13%. GlaxoSmithKline’s payout ratio is 0.86%.
In other GlaxoSmithKline news, insider Vivienne Cox bought 434 shares of GlaxoSmithKline stock in a transaction dated Wednesday, July 24th. The stock was purchased at an average price of GBX 1,654 ($21.61) per share, for a total transaction of £7,178.36 ($9,379.80). Insiders bought 456 shares of company stock valued at $753,737 in the last quarter.
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.
Featured Story: Dollar Cost Averaging
Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.